ATR-IN-11
Product Specifications
Target
Others|||ATM/ATR
Related Pathways
PI3K/Akt/mTOR signaling|||Others|||DNA Damage/DNA Repair
Bioactivity
ATR-IN-11 (Compound Hit01) is a potent inhibitor of ataxia capillaris and Rad3-related (ATR) kinases. As a promising lead compound for developing drugs targeting the ATR kinase, a key regulatory protein in the DNA damage response (DDR) that senses replication stress (RS), ATR-IN-11 has significant potential for cancer research.
Molecular Formula
C25H30N6O2
Molecular Weight
446.54
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1231354-01 0.5 mg (E-Coli)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details 
MBS1231354-02 0.05 mg (Baculovirus)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details 
MBS1231354-03 0.5 mg (Yeast)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details MBS1231354-04 0.05 mg (Mammalian-Cell)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details MBS1231354-05 1 mg (E-Coli)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details MBS1231354-06 0.1 mg (Baculovirus)
Recombinant Shigella boydii serotype 18 Cysteine desulfurase (sufS)
Ask
View Details